BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 27191028)

  • 1. VISCERAL LEISHMANIASIS FROM AN AREA PREVIOUSLY NOT KNOWN TO BE ENDEMIC; DANGUR, BENSHANGUL-GUMUZ, REGIONAL STATE, NORTHWEST ETHIOPIA: A CASE REPORT.
    Abera A; Tasew G; Degu A; Almneh M; Mulugeta A; Aseffa A; Gadisa E
    Ethiop Med J; 2016 Jan; 54(1):33-6. PubMed ID: 27191028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of asymptomatic visceral leishmaniasis in human and dog, Benishangul Gumuz regional state, Western Ethiopia.
    Bejano S; Shumie G; Kumar A; Asemahagn E; Damte D; Woldie S; Mulugeta A; Manaye N; Genetu A; Gadisa E; Mamo G
    Parasit Vectors; 2021 Jan; 14(1):39. PubMed ID: 33430946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Visceral Leishmaniasis in Benishangul-Gumuz Regional State, Western Ethiopia: Reemerging or Emerging?
    Abera A; Tasew G; Tsegaw T; Kejella A; Mulugeta A; Worku D; Aseffa A; Gadisa E
    Am J Trop Med Hyg; 2016 Jul; 95(1):104-8. PubMed ID: 27139445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emergence of visceral leishmaniasis in Sri Lanka: a newly established health threat.
    Siriwardana HVYD; Karunanayake P; Goonerathne L; Karunaweera ND
    Pathog Glob Health; 2017 Sep; 111(6):317-326. PubMed ID: 28820339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sodium stibogluconate-sensitive visceral leishmaniasis in the non-endemic hilly region of Uttarakhand, India.
    Verma SK; Ahmad S; Shirazi N; Kusum A; Kaushik RM; Barthwal SP
    Trans R Soc Trop Med Hyg; 2007 Jul; 101(7):730-2. PubMed ID: 17382981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Visceral leishmaniasis in selected communities of Hamar and Banna-Tsamai districts in Lower Omo Valley, South West Ethiopia: Sero-epidemological and Leishmanin Skin Test Surveys.
    Bekele F; Belay T; Zeynudin A; Hailu A
    PLoS One; 2018; 13(5):e0197430. PubMed ID: 29795589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Imported visceral leishmaniasis (kala azar) in a German infant].
    Emeis M; Liesenfeld O; Henze G; Meredith S; Schoone G; Stück B
    Klin Padiatr; 1995; 207(6):347-9. PubMed ID: 8569138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Asymptomatic leishmaniasis in kala-azar endemic areas of Malda district, West Bengal, India.
    Saha P; Ganguly S; Chatterjee M; Das SB; Kundu PK; Guha SK; Ghosh TK; Bera DK; Basu N; Maji AK
    PLoS Negl Trop Dis; 2017 Feb; 11(2):e0005391. PubMed ID: 28187202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changing Epidemiology: A New Focus of Kala-azar at High-Altitude Garhwal Region of North India.
    Kumar Bhat N; Ahuja V; Dhar M; Ahmad S; Pandita N; Gupta V; Chandra S
    J Trop Pediatr; 2017 Apr; 63(2):104-108. PubMed ID: 27582128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimony-induced cerebellar ataxia.
    Khalil EA; Ahmed AE; Musa AM; Hussein MH
    Saudi Med J; 2006 Jan; 27(1):90-2. PubMed ID: 16432602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Visceral leishmaniasis with an unusually long incubation time].
    Matzdorff AC; Matthes K; Kemkes-Matthes B; Pralle H
    Dtsch Med Wochenschr; 1997 Jul; 122(28-29):890-4. PubMed ID: 9264920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Visceral leishmaniasis: a rare cause of post-transplant fever and pancytopenia.
    Rajaram KG; Sud K; Kohli HS; Gupta KL; Sakhuja V
    J Assoc Physicians India; 2002 Jul; 50():979-80. PubMed ID: 12126362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of a combined treatment of sodium stibogluconate at 20mg/kg/day with upper maximum daily dose limit of 850mg and Paromomycin 15mg/kg/day in HIV negative visceral leishmaniasis patients. A retrospective study, northwest Ethiopia.
    Tamiru A; Mohammed R; Atnafu S; Medhin G; Hailu A
    PLoS Negl Trop Dis; 2021 Aug; 15(8):e0009713. PubMed ID: 34464401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Positive response to sodium antimony gluconate administration in visceral leishmaniasis seropositive patients.
    Chowdhury S; Haque F; al-Masum A; el Harith A; Karim E
    Am J Trop Med Hyg; 1991 Apr; 44(4):390-3. PubMed ID: 1645929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Visceral leishmaniasis in District Dir, NWFP.
    Rahim F; Rehman F; Ahmad S; Zada B
    J Pak Med Assoc; 1998 Jun; 48(6):161-2. PubMed ID: 9813985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Visceral leishmaniasis: a difficult diagnosis and unusual causative agent.
    Oren R; Schnur LF; Ben Yehuda D; Mayner V; Okon E; Rachmilewitz EA
    J Infect Dis; 1991 Oct; 164(4):746-9. PubMed ID: 1654358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Visceral leishmaniasis in Aba-Roba, south-western Ethiopia: prevalence and incidence of active and subclinical infections.
    Hailu A; Gramiccia M; Kager PA
    Ann Trop Med Parasitol; 2009 Dec; 103(8):659-70. PubMed ID: 20030990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urine antigen detection by latex agglutination test for diagnosis and assessment of initial cure of visceral leishmaniasis.
    Salam MA; Khan MG; Mondal D
    Trans R Soc Trop Med Hyg; 2011 May; 105(5):269-72. PubMed ID: 21353275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Visceral leishmaniasis in a renal transplant recipient: diagnostic and therapeutic problems.
    Sharma RK; Jha R; Kumar P; Kher V; Gupta A; Kumar A; Gulati S; Arora P; Murari M; Bhandari M
    Am J Nephrol; 1996; 16(4):358-60. PubMed ID: 8739293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiological, clinical & pharmacological study of antimony-resistant visceral leishmaniasis in Bihar, India.
    Thakur CP; Narayan S; Ranjan A
    Indian J Med Res; 2004 Sep; 120(3):166-72. PubMed ID: 15489554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.